Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gee

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
JAMA Cardiology|October 11, 2016
Announcing the New JAMACardiology.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
JAMA Ophthalmology|October 11, 2016
Announcing the New JAMAOphthalmology.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
JAMA Pediatrics|October 11, 2016
Announcing the New JAMAPediatrics.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
JAMA Facial Plastic Surgery|October 11, 2016
Announcing the New JAMAFacialPlasticSurgery.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
The New Zealand Medical Journal|October 8, 2020
The clinical toxicology of cannabisLeo J Schep, Robin J Slaughter, Paul Glue, et al.
BMJ (Clinical Research Ed.)|August 15, 2014
Regulating new psychoactive drugs: innovation leading to compromiseLeo J Schep, Paul Gee, Malcolm Tingle, et al.
Drug Testing and Analysis|October 21, 2011
Comments on BZP and New Zealand's alternative approach to prohibitionLeo J Schep, Robin J Slaughter, Wayne A Temple, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 2, 2015
Case series: toxicity from 25B-NBOMe--a cluster of N-bomb casesPaul Gee, Leo J Schep, Berit P Jensen, et al.
The New Zealand Medical Journal|February 2, 2023
Specialist medical toxicologist consultations provided by the New Zealand National Poisons Centre, 2018-2020Adam C Pomerleau, Paul Gee, D Michael G Beasley, et al.
Annals of Emergency Medicine|May 12, 2012
Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhagePaul Gee, Cheryl Tallon, Neil Long, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
JAMA Cardiology|October 11, 2016
Announcing the New JAMACardiology.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
JAMA Ophthalmology|October 11, 2016
Announcing the New JAMAOphthalmology.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
JAMA Pediatrics|October 11, 2016
Announcing the New JAMAPediatrics.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
JAMA Facial Plastic Surgery|October 11, 2016
Announcing the New JAMAFacialPlasticSurgery.comPaul Gee, Colleen Kelly, Michael Berkwits, et al.
The New Zealand Medical Journal|October 8, 2020
The clinical toxicology of cannabisLeo J Schep, Robin J Slaughter, Paul Glue, et al.
BMJ (Clinical Research Ed.)|August 15, 2014
Regulating new psychoactive drugs: innovation leading to compromiseLeo J Schep, Paul Gee, Malcolm Tingle, et al.
Drug Testing and Analysis|October 21, 2011
Comments on BZP and New Zealand's alternative approach to prohibitionLeo J Schep, Robin J Slaughter, Wayne A Temple, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 2, 2015
Case series: toxicity from 25B-NBOMe--a cluster of N-bomb casesPaul Gee, Leo J Schep, Berit P Jensen, et al.
The New Zealand Medical Journal|February 2, 2023
Specialist medical toxicologist consultations provided by the New Zealand National Poisons Centre, 2018-2020Adam C Pomerleau, Paul Gee, D Michael G Beasley, et al.
Annals of Emergency Medicine|May 12, 2012
Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhagePaul Gee, Cheryl Tallon, Neil Long, et al.
Pageof 4